GemPharmatech is a leading provider ofgenetically engineered mousemodels(GEMMs)and services to global preclinical R&D communities. We specialize in developing animal models using cutting edge gene-editing technologies with a large collection ofcKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.
GemPharmatech provides an expansive array of preclinical services, including mouse model customization, pharmacology services such as drug efficacy testing and mouse phenotyping, CRISPR/Cas9 gene-editing, cryopreservation, rapid expansion, and customized breeding. The company has developed one of the world's largest collections of mouse models to enable scientific innovation and accelerate drug development.